NCT07302113 Complete Cognitive Intervention for cSLE
| NCT ID | NCT07302113 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Andrea Knight |
| Condition | Lupus |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-01-15 |
| Primary Completion | 2027-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-01-15 with a primary completion date of 2027-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This project will work closely with patients to design and test a new program that supports brain health in children and youth with childhood-onset lupus (cSLE). The investigators will see how practical and helpful the program is for patients.
Eligibility Criteria
Inclusion Criteria: * Receive subject-informed consent; * Have a current diagnosis of cSLE that meets the 1997 American College of Rheumatology (ACR) or System Lupus International Collaborating Clinics (SLICC) classification criteria * Aged 13-18 years old Exclusion Criteria: * Conditions that significantly affect cognition (e.g., intellectual disability diagnosis, active psychosis), hearing loss or vision problems precluding participation in group * Non-English speaking * Lack of access to technology that would allow them to participate in the virtual intervention (e.g., phone, tablet, computer, etc.)
Contact & Investigator
Busi Zapparoli, PhD
PRINCIPAL INVESTIGATOR
The Hospital for Sick Children
Frequently Asked Questions
Who can join the NCT07302113 clinical trial?
This trial is open to participants of all sexes, aged 13 Years or older, up to 18 Years, studying Lupus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07302113 currently recruiting?
Yes, NCT07302113 is actively recruiting participants. Contact the research team at busi.zapparoli@sickkids.ca for enrollment information.
Where is the NCT07302113 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT07302113 clinical trial?
NCT07302113 is sponsored by Andrea Knight. The principal investigator is Busi Zapparoli, PhD at The Hospital for Sick Children. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.